Immunosuppressant and cytotoxic drugs: unapproved uses or indications.
Abel
E A
EA
Stanford University School of Medicine, California, USA.
D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D017277:Drug Approval; D004363:Drug Utilization; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D003879:Dermatologic Agents; D007155:Immunologic Factors; D007166:Immunosuppressive Agents